Ventas with ticker code (VTR) now have 18 market analysts covering the stock. The analyst consensus now points to a rating of ‘Buy’. The range between the high target price and low target price is between 80 and 45 calculating the average target price we see $54.89. Now with the previous closing price of $46.03 this indicates there is a potential upside of 19.2%. Also worth taking note is the 50 day moving average now sits at $49.28 and the 200 day MA is $47.26. The total market capitalization for the company now stands at $18,412m. Visit the company website at: https://www.ventasreit.com
The potential market cap would be $21,956m based on the market consensus.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries healthcare and real estate. As one of the world’s foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
The company has a dividend yield of 3.9% with the ex dividend date set at 31-3-2023 (DMY).
